How well does Vesanoid(Cemiplimab) work?

This section summarizes the clinical effectiveness of the drug.

Clinical Effectiveness

In clinical studies, VESANOID induced complete remission in 50% to 80% of patients with APL, including those with relapsed/refractory disease and newly diagnosed cases. The median time to achieve remission ranged from 40 to 50 days. The drug is typically used as part of a treatment regimen that includes consolidation chemotherapy.